Wechselwirkungen · Atazanavir Viatris (previously Atazanavir Mylan)
Atazanavir Viatris 150 mg hard capsules Atazanavir Viatris 200 mg hard capsules Atazanavir Viatris 300 mg hard capsules · Abschnitt 4.5 · PDF-Seite 12
HOS-223181 · Präparat HOS-217134
No significant effect on atazanavir concentrations was observed when administered with enteric-coated didanosine, but administration with food decreased didanosine concentrations. Tenofovir disoproxil fumarate Atazanavir AUC: ↓22% (↓35% ↓6%) * When co-administered 300 mg once daily Atazanavir Cmax : ↓16% (↓30% ↔0%) * with tenofovir (atazanavir 300 mg once daily Atazanavir Cmin : ↓23% (↓43% ↑2%) * disoproxil fumarate, it is with ritonavir 100 mg once daily) recommended that *In a combined analysis from several clinical atazanavir 300 mg be 300 mg tenofovir disoproxil studies, atazanavir/ritonavir 300/100 mg co- given with ritonavir 100 fumarate is equivalent to 245 mg administered with tenofovir disoproxil mg and tenofovir tenofovir disoproxil. fumarate 300 mg (n=39) was compared to disoproxil fumarate 300 atazanavir/ritonavir 300/100 mg (n=33). mg (all as a single dose Studies conducted in HIV-infected with food). patients
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): tenofovir (HOS-088083) tenofovir disoproxil (HOS-108843) didanosine (HOS-085836) fumarate (HOS-108845) tenofovir disoproxil fumarate (HOS-110471) ritonavir (HOS-084521)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-24T09:40:00Z · SHA-256 851799f19c7f91ccad410a9396697d8f19a238de0eeb6394755a929570f3b97b · Passage be4bac9467cc24f7b06b10b32451b10d75bfa71748d8fed027c41b91a437b5db · Zeichen 15345–16676 im Abschnitt